Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Events>This Event
  Events - January 2014


Pharmaceutical Microbiology

21 Jan 2014 - 22 Jan 2014 - London, UK



Bookmark and Share


SMi’s reputable Pharamceutical Microbiology conference returns for its 3rd installment on 20th and 21st January, 2014, London UK.

Pharmaceutical Microbiology 2014 will draw upon the experiences and knowledge from experts and specialists around the globe to provide first-class presentations and stimulating discussions.

The conference will aim to focus on the regulatory aspect, with topics addressing preparations for auditing, what to expect during the inspection process, and how to rectify poor situations. There will also be considerable spotlight on novel rapid methods, case studies from the USA, their implementation, and the current regulatory view on methods. Among these hot topics the event will also examine sterility assessment, risk management, and contamination control.

KEY BENEFITS OF ATTENDING:

Regulatory body representation and update – what to expect from inspection, how to prepare your lab, and how to rectify situations when things go wrong.

Discover cutting edge rapid methods, how to implement the technology, and the regulatory stance

Hear specialist advice on contamination control and risk management to minimise costs and maximise efficiency

Learn about hot topics which include objectionable organisms, viral contaminations, update on the pharmacopeias, and quality by design.

Discuss case studies and experiences with expert speakers and delegates from across the UK, USA, and Europe.

KEY SPEAKERS:

Phil Duncanson, Site Microbiologist & QC Lead, MedImmune

Mary-Anne Weatherhead, Qualified Person, Pfizer

Andrew Bartko, Senior Scientist, Battelle

William Wade, Professor of Oral Microbiology, Barts and The London

Brendan Gilmore, Senior Lecturer in Pharmaceutical Microbiology, Queen’s University Belfast

Amy McDaniel, Associate Director, Production Operations, Pfizer

Tim Eaton, Sterile Manufacturing Specialist, AstraZeneca

Pierre Raboisson, Head of Medicinal Chemistry, Johnson & Johnson

Olivier Chancel, Head of Pharmaceutical Support, Merial Sas (Sanofi)

Di Morris, Consultant, Pharmaceutical Solutions Ltd. (ex-MHRA)

Stephen Rawling, Microbiology Team Leader, GSK

John Duguid, Principal Process Analytical Scientist, Genzyme

Kim Bowers, Senior Supervisor, Pfizer

Hilary Chan, Quality Scientist IV, Pfizer

Erika Pfeiler, Microbiologist, FDA

Steven Donald, Microbiologist, FDA

The previous 2 events in the Microbiology series received positive feedback from the industry including Thermo Fischer Scientific – “The delegate quality was good” , Pfizer – “Topics were interesting and relevant” and Groninger & co gmbh- Very diverse multi facetted event

Be sure to take part in the next instalment by registering online at:

http://www.smi-online.co.uk/goto/2014pharma-microbiology29.asp

Alternatively contact John Collins on +44(0)20 7827 6734 or email jcollins@smi-online.co.uk


Further information
Scientific News
Point of Care Diagnostics - A Cautious Revolution
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
One Step Closer to Precision Medicine for Chronic Lung Disease Sufferers
A study led by University of North Carolina at Chapel Hill, and National Jewish Health, has provided evidence of links between SNPs and known COPD blood protein biomarkers.
Charles River Acquires Agilux
Enhances Charles River’s early-stage capabilities in bioanalytical services.
Scientists Find Lethal Vulnerability in Treatment-Resistant Lung Cancer
The study describes how the drug Selinexor killed lung cancer cells and shrank tumors in mice when used against cancers driven by the aggressive and difficult-to-treat KRAS cancer gene.
How Baby’s Genes Influence Birth Weight And Later Life Disease
The large-scale study could help to target new ways of preventing and treating these diseases.
Genes Underlying Dogs’ Social Ability Revealed
The social ability of dogs is affected by genes that also seem to influence human behaviour, according to a new study from Linköping University in Sweden.
‘Cellbots’ Chase Down Cancer, Deliver Drugs Directly to Tumors
Programmable T cells shown to be versatile, precise, and powerful in lab studies.
Drug to Treat Alcohol Use Disorder Shows Promise Among Drinkers With High Stress
The findings suggest that potential future studies with drugs targeting vasopressin blockade should focus on populations of people with AUD who also report high levels of stress.
C Dots Show Powerful Tumor Killing Effect
Nanoparticles known as Cornell dots, or C dots, have shown great promise as a therapeutic tool in the detection and treatment of cancer.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!